{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:27:53Z","timestamp":1793842073607,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pathological cardiac hypertrophy presents a important public health challenge, particularly in aging populations, highlighting the urgent need for novel therapeutic targets. This study investigates the role and molecular mechanisms of OTUD5 in pathological cardiac hypertrophy. OTUD5 expression is greatly increased in cardiomyocytes from hypertrophic hearts. Deleting cardiomyocyte-specific OTUD5 exacerbates myocardial hypertrophy induced by angiotensin II (Ang II) and transverse aortic constriction\u00a0(TAC). By contrast, targeted overexpression of OTUD5 in cardiomyocytes alleviates Ang II-induced pathological hypertrophy. Mechanistically, we demonstrate that OTUD5 regulates STAT3 activity by removing the K63-linked ubiquitin chain at lysine 283 (K283) on STAT3 through its C224 residue. This process inhibits both phosphorylation and nuclear translocation of STAT3, effectively relieving its transcriptional repression of PGC1\u03b1 and enhancing mitochondrial function within cardiomyocytes. Our research uncovers a new OTUD5\u2013STAT3\u2013PGC1\u03b1 axis that modulates mitochondrial bioenergetics, suggesting it as a potential therapeutic target for pathological cardiac hypertrophy.<\/jats:p>","DOI":"10.1038\/s12276-026-01870-5","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:14:00Z","timestamp":1792138440000},"page":"3579-3592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyocyte-enriched OTUD5 alleviates pathological myocardial hypertrophy by deubiquitinating STAT3 and modulating the STAT3\u2013PGC-1\u03b1 axis"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-0822","authenticated-orcid":false,"given":"Bozhi","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wante","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naijin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiren","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1603-3223","authenticated-orcid":false,"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","volume":"370","author":"FH Messerli","year":"2007","unstructured":"Messerli, F. H., Williams, B. & Ritz, E. Essential hypertension. Lancet 370, 591\u2013603 https:\/\/doi.org\/10.1016\/S0140-6736(07)61299-9 (2007).","journal-title":"Lancet"},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 https:\/\/doi.org\/10.1038\/s41569-018-0007-y (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"1870_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081161","volume":"12","author":"L Fu","year":"2023","unstructured":"Fu, L., Lu, K., Jiao, Q., Chen, X. & Jia, F. The regulation and double-edged roles of the deubiquitinase OTUD5. Cells 12, 1161 https:\/\/doi.org\/10.3390\/cells12081161 (2023).","journal-title":"Cells"},{"key":"1870_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s41423-020-00531-5","volume":"18","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING. Cell. Mol. Immunol. 18, 1945\u20131955 https:\/\/doi.org\/10.1038\/s41423-020-00531-5 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"1870_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41418-024-01293-7","volume":"31","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation. Cell Death Differ. 31, 753\u2013767 https:\/\/doi.org\/10.1038\/s41418-024-01293-7 (2024).","journal-title":"Cell Death Differ."},{"key":"1870_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301852","volume":"10","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Deubiquitinase OTUD5 as a novel protector against 4-HNE-triggered ferroptosis in myocardial ischemia\/reperfusion injury. Adv. Sci. 10, e2301852 https:\/\/doi.org\/10.1002\/advs.202301852 (2023).","journal-title":"Adv. Sci."},{"key":"1870_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44228-5","volume":"14","author":"LK Chu","year":"2023","unstructured":"Chu, L. K. et al. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury. Nat. Commun. 14, 8393 https:\/\/doi.org\/10.1038\/s41467-023-44228-5 (2023).","journal-title":"Nat. Commun."},{"key":"1870_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03382-x","volume":"22","author":"C Liu","year":"2025","unstructured":"Liu, C. et al. THBS1 in macrophage-derived exosomes exacerbates cerebral ischemia-reperfusion injury by inducing ferroptosis in endothelial cells. J. Neuroinflammation 22, 48 https:\/\/doi.org\/10.1186\/s12974-025-03382-x (2025).","journal-title":"J. Neuroinflammation"},{"key":"1870_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103614","volume":"82","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Extracellular vesicle-packaged GBP2 from macrophages aggravates sepsis-induced acute lung injury by promoting ferroptosis in pulmonary vascular endothelial cells. Redox Biol. 82, 103614 https:\/\/doi.org\/10.1016\/j.redox.2025.103614 (2025).","journal-title":"Redox Biol."},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang, L. et al. DYRK1B\u2013STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation 145, 829\u2013846 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055727 (2022).","journal-title":"Circulation"},{"key":"1870_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/cvr\/cvae116","volume":"120","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. Cardiomyocyte \u03b2II spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function. Cardiovasc. Res. 120, 1312\u20131326 https:\/\/doi.org\/10.1093\/cvr\/cvae116 (2024).","journal-title":"Cardiovasc. Res."},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1042\/CS20140648","volume":"128","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Vinexin-\u03b2 exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses. Clin. Sci. 128, 923\u2013936 https:\/\/doi.org\/10.1042\/CS20140648 (2015).","journal-title":"Clin. Sci."},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/ars.2019.7826","volume":"31","author":"S Manohar","year":"2019","unstructured":"Manohar, S. et al. Polyubiquitin chains linked by lysine residue 48 (K48) selectively target oxidized proteins in vivo. Antioxid. Redox Signal. 31, 1133\u20131149 https:\/\/doi.org\/10.1089\/ars.2019.7826 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"1870_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/257862","volume":"2011","author":"R Singh","year":"2011","unstructured":"Singh, R. Jak2-independent activation of Stat3 by intracellular angiotensin II in human mesangial cells. J. Signal Transduct. 2011, 257862 https:\/\/doi.org\/10.1155\/2011\/257862 (2011).","journal-title":"J. Signal Transduct."},{"key":"1870_CR15","doi-asserted-by":"publisher","first-page":"H186","DOI":"10.1152\/ajpheart.00531.2018","volume":"316","author":"JY Beak","year":"2019","unstructured":"Beak, J. Y. et al. The nuclear receptor ROR\u03b1 protects against angiotensin II-induced cardiac hypertrophy and heart failure. Am. J. Physiol. Heart Circ. Physiol. 316, H186\u2013H200 https:\/\/doi.org\/10.1152\/ajpheart.00531.2018 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1870_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020603","volume":"22","author":"M Tolomeo","year":"2021","unstructured":"Tolomeo, M. & Cascio, A. The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int. J. Mol. Sci. 22, 603 https:\/\/doi.org\/10.3390\/ijms22020603 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1161\/CIRCRESAHA.124.323595","volume":"135","author":"M Saleem","year":"2024","unstructured":"Saleem, M. et al. Myeloid-specific JAK2 contributes to inflammation and salt sensitivity of blood pressure. Circ. Res. 135, 890\u2013909 https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323595 (2024).","journal-title":"Circ. Res."},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s41375-018-0117-x","volume":"32","author":"B Wingelhofer","year":"2018","unstructured":"Wingelhofer, B. et al. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer. Leukemia 32, 1713\u20131726 https:\/\/doi.org\/10.1038\/s41375-018-0117-x (2018).","journal-title":"Leukemia"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/13543776.2015.1086749","volume":"25","author":"PS Lai","year":"2015","unstructured":"Lai, P. S. et al. A STAT inhibitor patent review: progress since 2011. Expert Opin. Ther. Pat. 25, 1397\u20131421 https:\/\/doi.org\/10.1517\/13543776.2015.1086749 (2015).","journal-title":"Expert Opin. Ther. Pat."},{"key":"1870_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104164","volume":"82","author":"A Yin","year":"2022","unstructured":"Yin, A. et al. Exercise-derived peptide protects against pathological cardiac remodeling. EBioMedicine 82, 104164 https:\/\/doi.org\/10.1016\/j.ebiom.2022.104164 (2022).","journal-title":"EBioMedicine"},{"key":"1870_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu8422","volume":"11","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. Cardiomyocyte-derived YOD1 promotes pathological cardiac hypertrophy by deubiquitinating and stabilizing STAT3. Sci. Adv. 11, eadu8422 https:\/\/doi.org\/10.1126\/sciadv.adu8422 (2025).","journal-title":"Sci. Adv."},{"key":"1870_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41418-025-01614-4","volume":"33","author":"Y Gao","year":"2026","unstructured":"Gao, Y. et al. RNF220 mediates K63-linked polyubiquitination of STAT3 and aggravates pathological cardiac hypertrophy. Cell Death Differ. 33, 945\u2013958 https:\/\/doi.org\/10.1038\/s41418-025-01614-4 (2026).","journal-title":"Cell Death Differ."},{"key":"1870_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168269","volume":"1872","author":"Y Shen","year":"2026","unstructured":"Shen, Y. et al. Cardiomyocytes FGFBP1 induction by STAT3 drives pathological cardiac remodeling. Biochim. Biophys. Acta Mol. Basis Dis. 1872, 168269 https:\/\/doi.org\/10.1016\/j.bbadis.2026.168269 (2026).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1870_CR24","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.2174\/0929867325666180719122729","volume":"26","author":"A Gelain","year":"2019","unstructured":"Gelain, A., Mori, M., Meneghetti, F. & Villa, S. Signal transducer and activator of transcription protein 3 (STAT3): an update on its direct inhibitors as promising anticancer agents. Curr. Med. Chem. 26, 5165\u20135206 https:\/\/doi.org\/10.2174\/0929867325666180719122729 (2019).","journal-title":"Curr. Med. Chem."},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.06.006","volume":"191","author":"JD Beebe","year":"2018","unstructured":"Beebe, J. D., Liu, J. Y. & Zhang, J. T. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we? Pharmacol. Ther. 191, 74\u201391 https:\/\/doi.org\/10.1016\/j.pharmthera.2018.06.006 (2018).","journal-title":"Pharmacol. Ther."},{"key":"1870_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171463","volume":"13","author":"SP Singh","year":"2024","unstructured":"Singh, S. P., Pathuri, G., Asch, A. S., Rao, C. V. & Madka, V. Stat3 inhibitors TTI-101 and SH5-07 suppress bladder cancer cell survival in 3D tumor models. Cells 13, 1463 https:\/\/doi.org\/10.3390\/cells13171463 (2024).","journal-title":"Cells"},{"key":"1870_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115355","volume":"207","author":"Y Ren","year":"2023","unstructured":"Ren, Y. et al. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease. Biochem. Pharmacol. 207, 115355 https:\/\/doi.org\/10.1016\/j.bcp.2022.115355 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41401-024-01366-w","volume":"46","author":"ZY Liu","year":"2025","unstructured":"Liu, Z. Y. et al. Inhibiting the Otub1\/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer. Acta Pharmacol. Sin. 46, 184\u2013195 https:\/\/doi.org\/10.1038\/s41401-024-01366-w (2025).","journal-title":"Acta Pharmacol. Sin."},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"e1003455","DOI":"10.1371\/journal.ppat.1003455","volume":"9","author":"G Nishanth","year":"2013","unstructured":"Nishanth, G. et al. CYLD enhances severe listeriosis by impairing IL-6\/STAT3-dependent fibrin production. PLoS Pathog. 9, e1003455 https:\/\/doi.org\/10.1371\/journal.ppat.1003455 (2013).","journal-title":"PLoS Pathog."},{"key":"1870_CR30","doi-asserted-by":"publisher","first-page":"e49567","DOI":"10.1371\/journal.pone.0049567","volume":"7","author":"J Wei","year":"2012","unstructured":"Wei, J. et al. The ubiquitin ligase TRAF6 negatively regulates the JAK\u2013STAT signaling pathway by binding to STAT3 and mediating its ubiquitination. PLoS One 7, e49567 https:\/\/doi.org\/10.1371\/journal.pone.0049567 (2012).","journal-title":"PLoS One"},{"key":"1870_CR31","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.7150\/thno.83340","volume":"13","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes. Theranostics 13, 2263\u20132280 https:\/\/doi.org\/10.7150\/thno.83340 (2023).","journal-title":"Theranostics"},{"key":"1870_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416478","volume":"12","author":"L Zhong","year":"2025","unstructured":"Zhong, L. et al. Cardiomyocyte-enriched USP20 ameliorates pathological cardiac hypertrophy by targeting STAT3 deubiquitination. Adv. Sci. 12, e2416478 https:\/\/doi.org\/10.1002\/advs.202416478 (2025).","journal-title":"Adv. Sci."},{"key":"1870_CR33","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1073\/pnas.1503152112","volume":"112","author":"M Dasgupta","year":"2015","unstructured":"Dasgupta, M., Dermawan, J. K., Willard, B. & Stark, G. R. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proc. Natl Acad. Sci. USA. 112, 3985\u20133990 https:\/\/doi.org\/10.1073\/pnas.1503152112 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1870_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08605-3","volume":"10","author":"JJ Cho","year":"2019","unstructured":"Cho, J. J. et al. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation. Nat. Commun. 10, 701 https:\/\/doi.org\/10.1038\/s41467-019-08605-3 (2019).","journal-title":"Nat. Commun."},{"key":"1870_CR35","doi-asserted-by":"publisher","first-page":"21499","DOI":"10.1073\/pnas.1016147107","volume":"107","author":"J Yang","year":"2010","unstructured":"Yang, J. et al. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc. Natl Acad. Sci. USA. 107, 21499\u201321504 https:\/\/doi.org\/10.1073\/pnas.1016147107 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1870_CR36","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","volume":"64","author":"J Dong","year":"2021","unstructured":"Dong, J., Cheng, X. D., Zhang, W. D. & Qin, J. J. Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation. J. Med. Chem. 64, 8884\u20138915 https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00629 (2021).","journal-title":"J. Med. Chem."},{"key":"1870_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh, O., Arroum, T., Morris, S. & Busch, K. B. PGC1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants 12, 1075 https:\/\/doi.org\/10.3390\/antiox12051075 (2023).","journal-title":"Antioxidants"},{"key":"1870_CR38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/CIRCRESAHA.119.315529","volume":"125","author":"X Zhu","year":"2019","unstructured":"Zhu, X. et al. Fine-tuning of PGC1\u03b1 expression regulates cardiac function and longevity. Circ. Res. 125, 707\u2013719 https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315529 (2019).","journal-title":"Circ. Res."},{"key":"1870_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nm980","volume":"10","author":"H Inoue","year":"2004","unstructured":"Inoue, H. et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 10, 168\u2013174 https:\/\/doi.org\/10.1038\/nm980 (2004).","journal-title":"Nat. Med."},{"key":"1870_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.25632","volume":"56","author":"B Wang","year":"2012","unstructured":"Wang, B., Hsu, S. H., Frankel, W., Ghoshal, K. & Jacob, S. T. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology 56, 186\u2013197 https:\/\/doi.org\/10.1002\/hep.25632 (2012).","journal-title":"Hepatology"},{"key":"1870_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49854-1","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury. Nat. Commun. 15, 5441 https:\/\/doi.org\/10.1038\/s41467-024-49854-1 (2024).","journal-title":"Nat. Commun."},{"key":"1870_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/CAD.0000000000001603","volume":"35","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Bergaptol inhibits glioma cell proliferation and induces apoptosis via STAT3\/Bcl-2 pathway. Anticancer Drugs 35, 535\u2013541 https:\/\/doi.org\/10.1097\/CAD.0000000000001603 (2024).","journal-title":"Anticancer Drugs"},{"key":"1870_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110309","volume":"38","author":"CS Mantsounga","year":"2022","unstructured":"Mantsounga, C. S. et al. Macrophage IL-1\u03b2 promotes arteriogenesis by autocrine STAT3- and NF-\u03baB-mediated transcription of pro-angiogenic VEGF-A. Cell Rep. 38, 110309 https:\/\/doi.org\/10.1016\/j.celrep.2022.110309 (2022).","journal-title":"Cell Rep."},{"key":"1870_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1158\/2326-6066.CIR-22-0896","volume":"11","author":"D Xiao","year":"2023","unstructured":"Xiao, D. et al. ANXA1 promotes tumor immune evasion by binding PARP1 and upregulating Stat3-induced expression of PD-L1 in multiple cancers. Cancer Immunol. Res. 11, 1367\u20131383 https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0896 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"1870_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar8356","volume":"10","author":"LJ Celada","year":"2018","unstructured":"Celada, L. J. et al. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production. Sci. Transl. Med. 10, eaar8356 https:\/\/doi.org\/10.1126\/scitranslmed.aar8356 (2018).","journal-title":"Sci. Transl. Med."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01870-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:05:14Z","timestamp":1793840714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01870-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01870-5","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests..","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}